Is GLDC p.Ala45= (c.135C>T) pathogenic?

GLDC p.Ala45= (c.135C>T) is classified Likely benign in GLDC (ClinVar, Single submitter, 1 submitter; last evaluated 2025-06-22). Ultra-rare (popmax 0.0178%, amr); Associated with glycine encephalopathy.

What condition is associated with GLDC p.Ala45= (c.135C>T)?

GLDC p.Ala45= (c.135C>T) is associated with glycine encephalopathy (ClinVar).

How common is GLDC p.Ala45= (c.135C>T) in the general population?

GLDC p.Ala45= (c.135C>T) is ultra-rare (popmax 0.0178%, amr) (gnomAD).

How is Glycine encephalopathy inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

GLDC p.Ala45=

c.135C>T · rs747904179 · VCV1146830

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Rare

ultra-rare (popmax 0.0178%, amr)

Conditions

glycine encephalopathy

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -0.046	GERP -2.9
Overall
CADD	10.68	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0178% Admixed American · 9/50,698 alleles

Filtering AF 0.00922% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00692%

Overall 0.0015% 23/1,538,368 alleles · ultra-rare exomes 16/1,386,396 · genomes 7/151,972 · joint denominator

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.0178%	5,633
Ashkenazi Jewishnot grpmax-eligible	0.00356%	28,112
Remaining individualsnot grpmax-eligible	0.00336%	29,749
South Asian	0.0012%	83,286
European (non-Finnish)	0.000874%	114,419

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: GLDC
Protein: p.Ala45=
Coding: c.135C>T
MANE Select: NM_000170
dbSNP: rs747904179
Type: single nucleotide variant
Location: chr9:6645365 (GRCh38)
Gene constraint: LOEUF 1.09 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 94.50 · 3 PDB
Residue 45: the 'disordered' region

Full GLDC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycine encephalopathy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycine encephalopathy (Orphanet):

Inheritance: Autosomal recessive
Onset: Infancy, Neonatal
Prevalence: 1-9 / 1 000 000 (Europe)

Similar variants

GLDC c.1401+1G>A Pathogenic/Likely pathogenic ★★ same condition
GLDC c.1580+2T>G Pathogenic ★★ same condition
GLDC c.1851-1G>A Pathogenic ★★ same condition
GLDC c.2053-2A>G Likely pathogenic ★★ same condition
GLDC c.2203-2A>G Pathogenic/Likely pathogenic ★★ same condition
GLDC c.2315+2T>A Pathogenic/Likely pathogenic ★★ same condition
GLDC c.2315+2T>G Pathogenic/Likely pathogenic ★★ same condition
GLDC c.2316-1G>A Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gldc-p-ala45 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown